1. Home
  2. CUBE vs ABVX Comparison

CUBE vs ABVX Comparison

Compare CUBE & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CubeSmart

CUBE

CubeSmart

HOLD

Current Price

$37.60

Market Cap

8.6B

Sector

Real Estate

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$114.59

Market Cap

9.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUBE
ABVX
Founded
2004
2013
Country
United States
France
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
9.2B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
CUBE
ABVX
Price
$37.60
$114.59
Analyst Decision
Buy
Strong Buy
Analyst Count
14
11
Target Price
$44.42
$130.09
AVG Volume (30 Days)
2.3M
1.8M
Earning Date
02-26-2026
08-11-2025
Dividend Yield
5.67%
N/A
EPS Growth
N/A
N/A
EPS
1.55
N/A
Revenue
$1,110,530,000.00
$6,231,374.00
Revenue This Year
$2.65
$6.80
Revenue Next Year
$2.55
N/A
P/E Ratio
$24.11
N/A
Revenue Growth
4.09
N/A
52 Week Low
$34.24
$4.77
52 Week High
$44.13
$148.83

Technical Indicators

Market Signals
Indicator
CUBE
ABVX
Relative Strength Index (RSI) 50.71 43.23
Support Level $37.30 $113.64
Resistance Level $39.73 $125.00
Average True Range (ATR) 0.79 7.69
MACD -0.07 -0.78
Stochastic Oscillator 42.90 27.53

Price Performance

Historical Comparison
CUBE
ABVX

About CUBE CubeSmart

CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Majority of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: